{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:25:34Z","timestamp":1790115934021,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T00:00:00Z","timestamp":1771113600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["965286"],"award-info":[{"award-number":["965286"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005971","name":"Deutsche Herzstiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005971","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ejim.2026.106774","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T21:03:33Z","timestamp":1771448613000},"page":"106774","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Major adverse cardiovascular and bleeding outcomes in paroxysmal vs. non-paroxysmal atrial fibrillation: an individual patient-level data analysis of a large cohort of patients from the COMBINE-AF"],"prefix":"10.1016","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0629-9248","authenticated-orcid":false,"given":"George","family":"Ntaios","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Goette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Palazzolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Ruff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Link","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth W.","family":"Mahaffey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9805-4562","authenticated-orcid":false,"given":"Anthony P.","family":"Carnicelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4126-1285","authenticated-orcid":false,"given":"John","family":"Eikelboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Granger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Wallentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4110-7675","authenticated-orcid":false,"given":"Robert P.","family":"Giugliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2026.106774_bib0001","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004267","article-title":"Stroke and mortality risk in patients with various patterns of atrial fibrillation: results from the ENGAGE AF-TIMI 48 trial (effective anticoagulation with factor Xa next generation in atrial fibrillation-thrombolysis in myocardial infarction 48)","volume":"10","author":"Link","year":"2017","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"10.1016\/j.ejim.2026.106774_bib0002","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1161\/CIRCULATIONAHA.124.069757","article-title":"Association of atrial fibrillation burden and mortality among patients with cardiac implantable electronic devices","volume":"150","author":"Peigh","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2026.106774_bib0003","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.ijcard.2012.04.131","article-title":"The type of atrial fibrillation is associated with long-term outcome in patients with acute ischemic stroke","volume":"167","author":"Ntaios","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ejim.2026.106774_bib0004","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/eurheartj\/ehu307","article-title":"Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in active-a and averroes","volume":"36","author":"Vanassche","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2026.106774_bib0005","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00392-020-01760-4","article-title":"Clinical risk predictors in atrial fibrillation patients following successful coronary stenting: ENTRUST-AF PCI sub-analysis","volume":"110","author":"Goette","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.ejim.2026.106774_bib0006","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.amjcard.2020.06.046","article-title":"Differences in thromboembolic complications between paroxysmal and persistent atrial fibrillation patients following electrical cardioversion (from the ENSURE-AF study)","volume":"131","author":"Goette","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejim.2026.106774_bib0007","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1038\/s41598-022-05688-9","article-title":"Long-term risk of adverse outcomes according to atrial fibrillation type","volume":"12","author":"Blum","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejim.2026.106774_bib0008","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jacc.2022.04.058","article-title":"Presenting pattern of atrial fibrillation and outcomes of early rhythm control therapy","volume":"80","author":"Goette","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2026.106774_bib0009","first-page":"25","article-title":"Risk of myocardial infarction and ischemic stroke in individuals with first-diagnosed paroxysmal vs. non-paroxysmal atrial fibrillation under anticoagulation","author":"Ntaios","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.ejim.2026.106774_bib0010","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ahj.2020.12.002","volume":"233","author":"Carnicelli","year":"2021","journal-title":"Am Heart J"},{"key":"10.1016\/j.ejim.2026.106774_bib0011","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/CIRCULATIONAHA.121.056355","article-title":"Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex","volume":"145","author":"Carnicelli","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2026.106774_bib0012","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2026.106774_bib0013","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2026.106774_bib0014","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2026.106774_bib0015","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2026.106774_bib0016","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1161\/CIRCULATIONAHA.107.187397","article-title":"Universal definition of myocardial infarction","volume":"116","author":"Thygesen","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2026.106774_bib0017","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.ahj.2009.02.005","article-title":"Rationale and design of RE-LY: randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran","volume":"157","author":"Ezekowitz","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.ejim.2026.106774_bib0018","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf251","article-title":"Performance of DOAC and HAS-BLED scores in predicting major bleeding in Asian patients with non-valvular atrial fibrillation receiving direct oral anticoagulants","volume":"27","author":"Chan","year":"2025","journal-title":"Europace"},{"key":"10.1016\/j.ejim.2026.106774_bib0019","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejim.2024.06.022","article-title":"Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: a report from a prospective European observational registry","volume":"128","author":"Mei","year":"2024","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2026.106774_bib0020","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1161\/CIRCULATIONAHA.123.064556","article-title":"Development and validation of the DOAC score: a novel bleeding risk prediction tool for patients with atrial fibrillation on direct-acting oral anticoagulants","volume":"148","author":"Aggarwal","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2026.106774_bib0021","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/eurheartj\/ehx042","article-title":"Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT","volume":"38","author":"Van Gelder","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2026.106774_bib0022","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022487","article-title":"Atrial high-rate episode duration thresholds and thromboembolic risk: a systematic review and meta-analysis","volume":"10","author":"Sagris","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ejim.2026.106774_bib0023","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jacc.2015.06.1313","article-title":"Cardiac fibrosis in patients with atrial fibrillation: mechanisms and clinical implications","volume":"66","author":"Dzeshka","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2026.106774_bib0024","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1148\/radiol.2019182629","article-title":"Left atrial fibrosis assessed with cardiac MRI in patients with paroxysmal and those with persistent atrial fibrillation","volume":"292","author":"Lee","year":"2019","journal-title":"Radiol Sep"},{"key":"10.1016\/j.ejim.2026.106774_bib0025","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.hrthm.2009.12.009","article-title":"Role of inflammation and oxidative stress in atrial fibrillation","volume":"7","author":"Li","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ejim.2026.106774_bib0026","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/eurheartj\/ehi645","article-title":"Is atrial fibrillation an inflammatory disorder?","volume":"27","author":"Boos","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2026.106774_bib0027","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00380-004-0800-x","article-title":"C-reactive protein elevation predicts the occurrence of atrial structural remodeling in patients with paroxysmal atrial fibrillation","volume":"20","author":"Watanabe","year":"2005","journal-title":"Heart Vessels"},{"key":"10.1016\/j.ejim.2026.106774_bib0028","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1161\/hc4901.101760","article-title":"C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation","volume":"104","author":"Chung","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2026.106774_bib0029","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.jacc.2015.07.086","article-title":"Matching the NOAC to the patient: remember the modifiable bleeding risk factors","volume":"66","author":"Lip","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2026.106774_bib0030","doi-asserted-by":"crossref","DOI":"10.3390\/cells10102605","article-title":"Atrial cardiomyopathy: pathophysiology and clinical consequences","volume":"10","author":"Goette","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ejim.2026.106774_bib0031","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3389\/fphys.2012.00236","article-title":"Oxidative stress and microcirculatory flow abnormalities in the ventricles during atrial fibrillation","volume":"3","author":"Goette","year":"2012","journal-title":"Front Physiol"},{"key":"10.1016\/j.ejim.2026.106774_bib0032","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1053\/euhj.2001.2894","article-title":"Effect of acute atrial fibrillation on phasic coronary blood flow pattern and flow reserve in humans","volume":"23","author":"Kochiadakis","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2026.106774_bib0033","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/s41598-022-04897-6","article-title":"A computational analysis of atrial fibrillation effects on coronary perfusion across the different myocardial layers","volume":"12","author":"Saglietto","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejim.2026.106774_bib0034","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/eurheartj\/ehp046","article-title":"Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles","volume":"30","author":"Goette","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2026.106774_bib0035","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1161\/CIRCULATIONAHA.111.029223","article-title":"Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins","volume":"124","author":"Reilly","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2026.106774_bib0036","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/jama.281.10.921","article-title":"Plaque rupture and sudden death related to exertion in men with coronary artery disease","volume":"281","author":"Burke","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2026.106774_bib0037","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/europace\/eux301","article-title":"Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on atrial fibrillation (EORP-AF) long-term general registry","volume":"20","author":"Boriani","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.ejim.2026.106774_bib0038","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.hroo.2021.09.015","article-title":"Heart failure with preserved ejection fraction: an alternative paradigm to explain the clinical implications of atrial fibrillation","volume":"2","author":"Ariyaratnam","year":"2021","journal-title":"Heart Rhythm O2"},{"key":"10.1016\/j.ejim.2026.106774_bib0039","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.hrthm.2021.01.021","article-title":"Atrial fibrillation burden and heart failure: data from 39,710 individuals with cardiac implanted electronic devices","volume":"18","author":"Steinberg","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ejim.2026.106774_bib0040","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf019","article-title":"Atrial fibrillation burden in clinical practice, research, and technology development: a clinical consensus statement of the European Society of Cardiology Council on Stroke and the European Heart Rhythm Association","volume":"27","author":"Doehner","year":"2025","journal-title":"Europace"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526000798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526000798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T04:13:53Z","timestamp":1780287233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620526000798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":40,"alternative-id":["S0953620526000798"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2026.106774","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Major adverse cardiovascular and bleeding outcomes in paroxysmal vs. non-paroxysmal atrial fibrillation: an individual patient-level data analysis of a large cohort of patients from the COMBINE-AF","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2026.106774","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}],"article-number":"106774"}}